[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Koutsioumpa et al., 2012 - Google Patents

8.7 PG receptors with phosphatase action in cancer and angiogenesis

Koutsioumpa et al., 2012

Document ID
16344350052655793947
Author
Koutsioumpa M
Papadimitriou E
Publication year
Publication venue
Extracellular Matrix: Pathobiology and Signaling; De Gruyter: Berlin, Germany

External Links

Snippet

The regulation of protein phosphorylation, whether on serine (Ser), threonine (Thr), or tyrosine (Tyr) residues, plays a pivotal role in virtually all aspects of eukaryotic development. From the regulation of the cell cycle to cellular proliferation and differentiation, the delicate …
Continue reading at www.degruyter.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Miyamoto et al. Heparin‐binding epidermal growth factor‐like growth factor as a novel targeting molecule for cancer therapy
Klingelhöfer et al. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis‐promoting S100A4 protein
Whiteford et al. Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148
Iwama et al. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
Kligman et al. The S100 protein family
Bernfield et al. Functions of cell surface heparan sulfate proteoglycans
Eun et al. IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release
Mikelis et al. Integrin αvβ3 is a pleiotrophin receptor required for pleiotrophin‐induced endothelial cell migration through receptor protein tyrosine phosphatase β/ζ
Moussa et al. Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin
Parker et al. Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin
Hu et al. Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator
Farshi et al. Dual roles of the Cardin-Weintraub motif in multimeric Sonic hedgehog
Beltran et al. Receptor protein tyrosine phosphatases as mediators of cellular adhesion
Woodford-Thomas et al. The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hematopoietic cells
Shemesh et al. NKp44-derived peptide binds proliferating cell nuclear antigen and mediates tumor cell death
Woodgett et al. Protein kinase C and its role in cell growth
Nikolaienko et al. Receptor protein tyrosine phosphatases and cancer: new insights from structural biology
Formisano et al. PED/PEA‐15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis
Wu et al. Isolation of a novel basic FGF‐binding peptide with potent antiangiogenetic activity
Jay et al. Engineered bivalent ligands to bias ErbB receptor-mediated signaling and phenotypes
Toivanen et al. Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling
Wang et al. A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases
El-Chemaly et al. Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc–dependent transcripts in human lung fibroblasts
Koutsioumpa et al. 8.7 PG receptors with phosphatase action in cancer and angiogenesis
Kim et al. Linker region of Akt1/protein kinase Bα mediates platelet-derived growth factor-induced translocation and cell migration